Mechanisms Of Drug-induced Toxicities
药物引起的毒性机制
基本信息
- 批准号:7594368
- 负责人:
- 金额:$ 206.43万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:AcetaminophenAcute Liver FailureAnimal ModelAnnual ReportsAntidiabetic DrugsAntihypertensive AgentsBiologicalBloodCellsCholestasisChronic HepatitisCirrhosisClassConditionCorticosteroneDoseFaceFlow CytometryGenetic PolymorphismGenomeGlucocorticoid ReceptorGranulomaHepaticHepatoprotective AgentHerbal MedicineImmunoblastic LymphadenopathyIndustryInhalation AnestheticsInjuryInterleukin 4 ReceptorInterleukin-10Interleukin-13Interleukin-4Interleukin-6InterleukinsKnowledgeLesionLifeLinkLipidsLiverLiver RegenerationLiver diseasesMAPK9 geneMarketingMediatingMigration Inhibitory FactorMitogen-Activated Protein KinasesMonitorMusNatureNon-Steroidal Anti-Inflammatory AgentsPharmaceutical PreparationsPlayPredispositionProtein OverexpressionPsychotropic DrugsPublic HealthReactionResearchRiskRoleSerumSeveritiesStressT-LymphocyteTestingToxic effectWild Type Mouseantimicrobial drugbasecyclooxygenase 2cytokinedrug induced liver diseasedrug mechanismmRNA Expressionmonocyteneutrophilosteopontinphenylpyruvate tautomerasepost-marketprospective
项目摘要
ANNUAL REPORT FOR 2007
1. This year flow cytometry revealed that the hepatoprotective effects of interleukin (IL)-4 in AILI appeared to be due in part to the regulatory actions of this cytokine on infiltrating neutrophils and monocytes that express IL-4 receptors.
2. This year genome-wide mRNA expression analysis led to the discovery of numerous cellular factors that may play a role in the hepatoprotective effects of IL-13 in AILI.
3. This year we discovered that NK(T) cells played a role in AILI in IL-13 deficient mice, but not in wild type mice suggesting that IL-13 regulates these cells.
4. This year we discovered that endogenous corticosterone released into the blood as a result of hepatocellular injury enhanced the severity of AILI through a mechanism(s) that is mediated by its glucocorticoid receptor.
5. This year we found that stress-induced activation of the mitogen-activated protein kinase, JNK2, protected mice from AILI in part by promoting liver regeneration.
2007年年度报告
1. 今年的流式细胞术显示,白细胞介素 (IL)-4 在 AILI 中的保肝作用似乎部分归因于该细胞因子对表达 IL-4 受体的浸润性中性粒细胞和单核细胞的调节作用。
2. 今年全基因组 mRNA 表达分析发现了许多细胞因子,这些因子可能在 IL-13 对 AILI 的保肝作用中发挥作用。
3. 今年,我们发现 NK(T) 细胞在 IL-13 缺陷小鼠的 AILI 中发挥作用,但在野生型小鼠中则不然,表明 IL-13 调节这些细胞。
4. 今年,我们发现,由于肝细胞损伤,内源性皮质酮释放到血液中,通过其糖皮质激素受体介导的机制增强了 AILI 的严重程度。
5. 今年,我们发现应激诱导的丝裂原激活蛋白激酶 JNK2 的激活部分通过促进肝脏再生来保护小鼠免受 AILI。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Lance R Pohl其他文献
Lance R Pohl的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Lance R Pohl', 18)}}的其他基金
Role of Innate and Adaptive Immune Systems in Drug-Induced Liver Disease
先天性和适应性免疫系统在药物性肝病中的作用
- 批准号:
8344879 - 财政年份:
- 资助金额:
$ 206.43万 - 项目类别:
Role of Innate and Adaptive Immune Systems in Drug-Induced Liver Disease
先天性和适应性免疫系统在药物性肝病中的作用
- 批准号:
8558025 - 财政年份:
- 资助金额:
$ 206.43万 - 项目类别:
相似海外基金
Senescent hepatocytes mediate reprogramming of immune cells in acute liver failure
衰老肝细胞介导急性肝衰竭中免疫细胞的重编程
- 批准号:
10679938 - 财政年份:2023
- 资助金额:
$ 206.43万 - 项目类别:
Hepatocytes Encapsulated with mesenchymal stromal cells in alginate microbeads for the treatment of acute Liver failure in Paediatric patients (HELP)
将间充质基质细胞封装在藻酸盐微珠中的肝细胞用于治疗儿科患者的急性肝衰竭(HELP)
- 批准号:
MR/V038583/1 - 财政年份:2022
- 资助金额:
$ 206.43万 - 项目类别:
Research Grant
Development of the innovative treatment using self iPS cell for acute liver failure
开发利用自身 iPS 细胞治疗急性肝衰竭的创新疗法
- 批准号:
21K08685 - 财政年份:2021
- 资助金额:
$ 206.43万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Pediatric Acute Liver Failure Immune Response Network (PALF IRN): Treatment for Immune Mediated Pathophysiology (TRIUMPH)
小儿急性肝衰竭免疫反应网络 (PALF IRN):免疫介导的病理生理学治疗 (TRIUMPH)
- 批准号:
10421290 - 财政年份:2021
- 资助金额:
$ 206.43万 - 项目类别:
Pediatric Acute Liver Failure Immune Response Network (PALF IRN): Treatment for Immune Mediated Pathophysiology (TRIUMPH)
小儿急性肝衰竭免疫反应网络 (PALF IRN):免疫介导的病理生理学治疗 (TRIUMPH)
- 批准号:
10180251 - 财政年份:2021
- 资助金额:
$ 206.43万 - 项目类别:
Therapeutic effect of plasmacytoid dendritic cells transplantation for acute liver failure
浆细胞样树突状细胞移植治疗急性肝衰竭的疗效
- 批准号:
20K21607 - 财政年份:2020
- 资助金额:
$ 206.43万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Macrophage Therapy for Acute Liver Failure
巨噬细胞治疗急性肝衰竭
- 批准号:
MR/T044802/1 - 财政年份:2020
- 资助金额:
$ 206.43万 - 项目类别:
Research Grant
Investigation of an optimal environment for the proliferation of mature hepatocytes toward the rescue of acute liver failure patients
研究成熟肝细胞增殖的最佳环境以挽救急性肝衰竭患者
- 批准号:
19K08475 - 财政年份:2019
- 资助金额:
$ 206.43万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Pediatric Acute Liver Failure (PALF) TReatment for ImmUne Mediated PathopHysiology (TRIUMPH)
小儿急性肝衰竭 (PALF) 免疫介导病理生理学治疗 (TRIUMPH)
- 批准号:
9789253 - 财政年份:2018
- 资助金额:
$ 206.43万 - 项目类别:
Cryopreservation of hiPS-derivd hepatic progenitor cells and application to acute liver failure treatment
hiPS源性肝祖细胞的冷冻保存及其在急性肝衰竭治疗中的应用
- 批准号:
18K08662 - 财政年份:2018
- 资助金额:
$ 206.43万 - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




